Medical Nutrition Therapy for Medically Complex Infants in the Pediatric Outpatient Setting
Medical Nutrition Therapy for Medically Complex Infants in the Pediatric Outpatient Setting. A Quality Improvement Project
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Candice R Poland, MS, RD, LD
- Phone Number: 713-486-6961
- Email: Candice.R.Poland@uth.tmc.edu
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- The University of Texas Health Science Center at Houston
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients who are admitted between July, 2018 and June, 2019 to the Neonatal High-Risk Clinic (NHRC) and High Risk Children's Clinic (HRCC) at UT Health from a neonatal intensive care unit (NICU)
Exclusion Criteria:
- short bowel syndrome,
- requiring parenteral nutrition (PN)
- active cancer
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Standardized Medical Nutrition Therapy
Standardized Medical Nutrition Therapy will include nutrition assessment provided by a registered dietitian (RD) at initial clinic visit or first Well Child Check (WCC) and regularly scheduled nutrition follow-up at each WCC visit thereafter.
|
Standardized Medical Nutrition Therapy will include nutrition assessment provided by a registered dietitian (RD) at initial clinic visit or first Well Child Check (WCC) and regularly scheduled nutrition follow-up at each WCC visit thereafter.
|
|
ACTIVE_COMPARATOR: Usual Care
At the primary care provider's discretion, a nutrition consult can be requested for the RD to perform nutrition assessment or discuss the patient's plan without full nutrition assessment, as is current practice.
Currently in the Neonatal High-Risk Clinic (NHRC) and High Risk Children's Clinic (HRCC) at UTHealth, providers consult the RD as deemed appropriate with no established criteria for when to include the RD in patient care.
Usual care will not be modified by the study protocol.
|
At the primary care provider's discretion, a nutrition consult can be requested for the RD to perform nutrition assessment or discuss the patient's plan without full nutrition assessment, as is current practice.
Currently in the Neonatal High-Risk Clinic (NHRC) and High Risk Children's Clinic (HRCC) at UTHealth, providers consult the RD as deemed appropriate with no established criteria for when to include the RD in patient care.
Usual care will not be modified by the study protocol.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of participants with a 20% improvement in growth velocity at 1 year corrected gestational age (CGA)
Time Frame: 4 months corrected gestational age (CGA)
|
4 months corrected gestational age (CGA)
|
|
Number of participants with a 20% improvement in growth velocity at 1 year corrected gestational age (CGA)
Time Frame: 8 months corrected gestational age (CGA)
|
8 months corrected gestational age (CGA)
|
|
Number of participants with a 20% improvement in growth velocity at 1 year corrected gestational age (CGA)
Time Frame: 12 months corrected gestational age (CGA)
|
12 months corrected gestational age (CGA)
|
|
Number of participants with a 20% improvement in growth velocity at 1 year corrected gestational age (CGA)
Time Frame: 1 year corrected gestational age (CGA)
|
1 year corrected gestational age (CGA)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with growth failure
Time Frame: 1 year corrected gestational age (CGA)
|
Growth failure ("Failure to Thrive") is defined as crossing 2 growth percentiles in a downward trajectory in the first year of life per child.
|
1 year corrected gestational age (CGA)
|
|
Number of participants who are malnourished
Time Frame: 1 year corrected gestational age (CGA)
|
The Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition (AND/ASPEN) criteria are used for diagnosing pediatric malnutrition.
|
1 year corrected gestational age (CGA)
|
|
Severity of malnutrition as assessed by the AND/ASPEN criteria
Time Frame: 1 year corrected gestational age (CGA)
|
1 year corrected gestational age (CGA)
|
|
|
Number of emergency department visits
Time Frame: 1 year corrected gestational age (CGA)
|
1 year corrected gestational age (CGA)
|
|
|
Number of hospitalizations
Time Frame: 1 year corrected gestational age (CGA)
|
1 year corrected gestational age (CGA)
|
|
|
Length of stay
Time Frame: about 3 to 7 days
|
number of hospital days
|
about 3 to 7 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Candice R Poland, MS, RD, LD, The University of Texas Health Science Center, Houston
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- HSC-MS-18-0276
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.